Alleviare India Logo


ZYDELIG (idelalisib) is a targeted therapy. It is an oral Phosphatidylinositol 3-kinase inhibitor. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Zydelig (idelalisib) tablets are for oral administration. Each tablet contains either 100 mg or 150 mg of idelalisib with the following inactive ingredients: microcrystalline cellulose, hydroxypropyl etc.

ZYDELIG is a prescription medicine used to treat adults with: Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia (CLL) in combination with Rituxan ® (rituximab) when CLL comes back after prior cancer treatment and when Rituxan treatment alone may be used due to other health problems.

ZYDELIG (idelalisib) Tablets suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.


ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship ZYDELIG (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. ZYDELIG is manufactured by Gilead Sciences, Inc.

ALLEVIARE LIFE SCIENCES provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for ZYDELIG (idelalisib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Zydelig is a kinase inhibitor indicated for the treatment of patients with:

Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.

Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.

Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies.

Medicine Name: ZYDELIG
Generic Name: Idelalisib
Approval Date: July 23, 2014
Available as (Form & Strength): 100 mg and 150 mg Tablets
Company Name: Gilead Sciences, Inc.

Please contact +91 9818274099 for ZYDELIG price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer�s requirements.

zydelig 150 mg

ZYDELIG (idelalisib) is available.

Get In Touch

    ZYDELIG (idelalisib) Tablets suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZYDELIG (idelalisib) Tablets on prescription and Import License in Patient’s Name only.

    For foreign countries patients, ZYDELIG (idelalisib) Tablets can be made available in Send your inquiry to find ZYDELIG (idelalisib) Tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for ZYDELIG (idelalisib) Tablets

    For ZYDELIG (idelalisib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details